About
O'Day holds a bachelor's degree in biology from Georgetown University and an MBA from Columbia University. At Roche he held executive positions in the pharmaceutical and diagnostics divisions in North America, Europe and Asia and sat on the Roche Corporate Executive Committee. He serves on the boards of PhRMA and Georgetown University. Other pharmaceutical chiefs with pages on Whoo include David Ricks of Eli Lilly, Robert Bradway of Amgen and Chris Boerner of Bristol Myers Squibb.
Whoo compiled this page from public sources: Gilead leadership page, Gilead third quarter 2026 results, UC Berkeley Haas newsroom. It is not affiliated with or endorsed by Daniel O'Day. Are you Daniel O'Day? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-17.
Want a page like this? Create yours from your résumé.
Experience
Chairman and Chief Executive Officer — Gilead Sciences
March 2019 – Present
- Leads the company in both roles
- Served on Roche's Corporate Executive Committee
- Held executive positions in pharmaceutical and diagnostics divisions in North America, Europe and Asia over about three decades